Skip to main content

Table 2 Angiographic and procedural characteristics

From: Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

Variables

DM n = 81

Non-DM n = 173

P-value

Vessel

 LM/LAD/LCX/RCA

2/38/14/27

4/97/29/43

0.498

 Type B2/C lesions

68 (84%)

133 (76.9%)

0.196

Lesions

 Lesion lengths, mm

25.81 ± 10.82

23.86 ± 11.02

0.187

 Ostial location

9 (11.1%)

18 (10.4%)

0.865

 Angulation > 45°

34 (42%)

58 (33.5%)

0.209

 Moderate-severe calcification

16 (19.8%)

30 (17.3%)

0.727

 Bifurcation

19 (23.5%)

49 (28.5%)

0.449

Repeat DES

 Type (EES/ZES)

37/44

69/104

0.414

 Number of stents (n)

1.61 ± 0.92

1.75 ± 0.89

0.263

 Stent length (mm)

27.21 ± 10.92

24.65 ± 10.83

0.082

 Stent diameter (mm)

2.86 ± 0.41

2.93 ± 0.39

0.234

  1. Data are presented as mean ± SD or n (%)
  2. LM left main coronary artery, LAD left anterior descending coronary artery, LCX left circumflex artery coronary artery, RCA right coronary artery, EES Everolimus Eluting Stent, ZES Zotarolimus Eluting Stent